HDAC inhibitors potentiate the activity of the BCR/ABL kinase inhibitor KW-2449 in imatinib-sensitive or -resistant BCR/ABL+ leukemia cells in vitro and in vivo
udgivet i: Clinical Cancer Research
dato for udgivelse: 2011-04-07
sprog: engelsk
main subject: cellelinje, leukæmi
Cites articles 40
- 2010-10-01
- 2007-01
Date
Titel
Artikel - wd:Q34988013